These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12090469)
21. Tolerance of glycosylphosphatidylinositol (GPI)-specific phospholipase D overexpression by Chinese hamster ovary cell mutants with aberrant GPI biosynthesis. Du X; Cai J; Zhou JZ; Stevens VL; Low MG Biochem J; 2002 Jan; 361(Pt 1):113-8. PubMed ID: 11742535 [TBL] [Abstract][Full Text] [Related]
22. Expression of intracellular and GPI-anchored forms of GPI-specific phospholipase D in COS-1 cells. Küng M; Bütikofer P; Brodbeck U; Stadelmann B Biochim Biophys Acta; 1997 Jul; 1357(3):329-38. PubMed ID: 9268057 [TBL] [Abstract][Full Text] [Related]
23. An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Brunner G; Metz CN; Nguyen H; Gabrilove J; Patel SR; Davitz MA; Rifkin DB; Wilson EL Blood; 1994 Apr; 83(8):2115-25. PubMed ID: 8161780 [TBL] [Abstract][Full Text] [Related]
24. Production of the glycosylphosphatidylinositol-specific phospholipase D by the islets of Langerhans. Metz CN; Zhang YY; Guo Y; Tsang TC; Kochan JP; Altszuler N; Davitz MA J Biol Chem; 1991 Sep; 266(27):17733-6. PubMed ID: 1833386 [TBL] [Abstract][Full Text] [Related]
25. Glycosylphosphatidylinositol-specific phospholipase D is localized in keratinocytes. Xie M; Sesko AM; Low MG Am J Physiol; 1993 Oct; 265(4 Pt 1):C1156-68. PubMed ID: 8238306 [TBL] [Abstract][Full Text] [Related]
26. Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes. O'Brien KD; Pineda C; Chiu WS; Bowen R; Deeg MA Circulation; 1999 Jun; 99(22):2876-82. PubMed ID: 10359731 [TBL] [Abstract][Full Text] [Related]
27. Expression of the ATDC (ataxia telangiectasia group D-complementing) gene in A431 human squamous carcinoma cells. Laderoute KR; Knapp AM; Green CJ; Sutherland RM; Kapp LN Int J Cancer; 1996 Jun; 66(6):772-8. PubMed ID: 8647648 [TBL] [Abstract][Full Text] [Related]
28. Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme. Naghibalhossaini F; Ebadi P Cancer Lett; 2006 Mar; 234(2):158-67. PubMed ID: 15893415 [TBL] [Abstract][Full Text] [Related]
29. Posttranslational modification of glycosylphosphatidylinositol (GPI)-specific phospholipase D and its activity in cleavage of GPI anchors. Tsujioka H; Misumi Y; Takami N; Ikehara Y Biochem Biophys Res Commun; 1998 Oct; 251(3):737-43. PubMed ID: 9790979 [TBL] [Abstract][Full Text] [Related]
30. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091 [TBL] [Abstract][Full Text] [Related]
31. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC. Ritorto MS; Rhode H; Vogel A; Borlak J Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633 [TBL] [Abstract][Full Text] [Related]
32. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells. Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309 [TBL] [Abstract][Full Text] [Related]
33. Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins. Low MG; Huang KS Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):483-93. PubMed ID: 1835378 [TBL] [Abstract][Full Text] [Related]
34. Phosphorylation decreases trypsin activation and apolipoprotein al binding to glycosylphosphatidylinositol-specific phospholipase D. Deeg MA; Bowen RF Biochem Cell Biol; 2002; 80(2):253-60. PubMed ID: 11989719 [TBL] [Abstract][Full Text] [Related]
35. Upregulated phospholipase D activity toward glycosylphosphatidylinositol-anchored proteins in micelle-like serum complexes in metabolically deranged rats and humans. Müller GA; Tschöp MH; Müller TD Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E462-E479. PubMed ID: 31961708 [TBL] [Abstract][Full Text] [Related]
36. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. Raikwar NS; Cho WK; Bowen RF; Deeg MA Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662 [TBL] [Abstract][Full Text] [Related]
38. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744 [TBL] [Abstract][Full Text] [Related]
39. Phospholipase D confers rapamycin resistance in human breast cancer cells. Chen Y; Zheng Y; Foster DA Oncogene; 2003 Jun; 22(25):3937-42. PubMed ID: 12813467 [TBL] [Abstract][Full Text] [Related]
40. Cleavage of carcinoembryonic antigen induces metastatic potential in colorectal carcinoma. Yamamoto Y; Hirakawa E; Mori S; Hamada Y; Kawaguchi N; Matsuura N Biochem Biophys Res Commun; 2005 Jul; 333(1):223-9. PubMed ID: 15958210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]